Holen Sie sich die Stockscreener-App
1.41
1.44%
0.02
Finanzdaten der OS Therapies Incorporated-Aktie (OSTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
17.37%
6.0744
|
7.3517 | 8.7967 | 3.7553 | 2.4995 |
| Depreciation and Amortization |
0.00%
0.1249
|
0.1249 | 0.1249 | 0.1249 | - |
| Operating Income/Loss |
15.66%
-8.5756
|
-10.17 | -11.99 | -6.8796 | -4.8387 |
| Nonoperating Income/Loss |
75.20%
-0.0568
|
-0.2289 | -1.4729 | 0.000065 | 0.3021 |
Net Income/Loss
|
16.97%
-8.6324
|
-10.40 | -13.46 | -6.8795 | -4.5366 |
| Diluted Average Shares |
13.52%
43.90
|
38.67 | - | 31.96 | 25.11 |
| Basic Earnings Per Share |
25.93%
-0.20
|
-0.27 | - | -0.21 | -0.19 |
| Diluted Earnings Per Share |
25.93%
-0.20
|
-0.27 | - | -0.21 | -0.19 |
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):